Cited 0 times in
Comparison of CD20 Binding Affinities of Rituximab Produced in Nicotiana benthamiana Leaves and Arabidopsis thaliana Callus
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김주영 | - |
dc.date.accessioned | 2021-12-28T17:32:35Z | - |
dc.date.available | 2021-12-28T17:32:35Z | - |
dc.date.issued | 2021-11 | - |
dc.identifier.issn | 1073-6085 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/187151 | - |
dc.description.abstract | Plants are promising drug-production platforms with high economic efficiency, stability, and convenience in mass production. However, studies comparing the equivalency between the original antibodies and those produced in plants are limited. Amino acid sequences that constitute the Fab region of an antibody are diverse, and the post-transcriptional modifications that occur according to these sequences in animals and plants are also highly variable. In this study, rituximab, a blockbuster antibody drug used in the treatment of non-Hodgkin's lymphoma, was produced in Nicotiana benthamiana leaves and Arabidopsis thaliana callus, and was compared to the original rituximab produced in CHO cells. Interestingly, the epitope recognition and antigen-binding abilities of rituximab from N. benthamiana leaves were almost lost. In the case of rituximab produced in A. thaliana callus, the specific binding ability and CD20 capping activity were maintained, but the binding affinity was less than 50% of that of original rituximab from CHO cells. These results suggest that different plant species exhibit different binding affinities. Accordingly, in addition to the differences in PTMs between mammals and plants, the differences between the species must also be considered in the process of producing antibodies in plants. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Humana Press | - |
dc.relation.isPartOf | MOLECULAR BIOTECHNOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Comparison of CD20 Binding Affinities of Rituximab Produced in Nicotiana benthamiana Leaves and Arabidopsis thaliana Callus | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pharmacology (약리학교실) | - |
dc.contributor.googleauthor | Cho Eun Kang | - |
dc.contributor.googleauthor | Seungeun Lee | - |
dc.contributor.googleauthor | Dong Hye Seo | - |
dc.contributor.googleauthor | Woon Heo | - |
dc.contributor.googleauthor | Sun Hyung Kwon | - |
dc.contributor.googleauthor | JeongRyeol Kim | - |
dc.contributor.googleauthor | Jinu Lee | - |
dc.contributor.googleauthor | Byoung Joon Ko | - |
dc.contributor.googleauthor | Hisashi Koiwa | - |
dc.contributor.googleauthor | Woo Taek Kim | - |
dc.contributor.googleauthor | Joo Young Kim | - |
dc.identifier.doi | 10.1007/s12033-021-00360-5 | - |
dc.contributor.localId | A00942 | - |
dc.relation.journalcode | J02250 | - |
dc.identifier.eissn | 1559-0305 | - |
dc.identifier.pmid | 34185248 | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2Fs12033-021-00360-5 | - |
dc.subject.keyword | Anti-CD20 antibody | - |
dc.subject.keyword | Arabidopsis thaliana | - |
dc.subject.keyword | B cells | - |
dc.subject.keyword | Epitope recognition | - |
dc.subject.keyword | Plant-based protein expression | - |
dc.subject.keyword | Rituximab | - |
dc.subject.keyword | Tobacco (Nicotiana benthamiana L.) | - |
dc.contributor.alternativeName | Kim, Joo Young | - |
dc.contributor.affiliatedAuthor | 김주영 | - |
dc.citation.volume | 63 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1016 | - |
dc.citation.endPage | 1029 | - |
dc.identifier.bibliographicCitation | MOLECULAR BIOTECHNOLOGY, Vol.63(11) : 1016-1029, 2021-11 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.